KOPRAN LTDPembelian
KOPRAN - Multiyear breakout - Cup and Handle - Monthly
KOPRAN - Multiyear breakout - Cup and Handle - Monthly
Kopran Ltd. is a fully integrated pharmaceutical company that manufactures and supplies high-quality formulations and active pharmaceutical ingredients globally.
Name - KOPRAN
Pattern - Cup and Handle
Timeframe - Monthly
Status - Breakout
Volume - Very Good
Cmp - 335
Target - 655
SL - 326 and 290
Fundamentals:
Company is virtually debt free.
Company has a healthy Interest coverage ratio of 10.89.
The company has an efficient Cash Conversion Cycle of 43.79 days.
Company has a healthy liquidity position with current ratio of 2.22.
The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.33.
The company has shown a poor revenue growth of 14.84% for the Past 3 years.
Company has a poor ROE of 6.79% over the past 3 years.
Price ₹ 336 M.Cap ₹ 1,617 Cr PE 27.3
Item YOY Jun 2024 Mar 2024 Jun 2023
Sales ⇡ 19% 139 186 117
EBIDT ⇡ 188% 18.2 21.7 6.31
Net profit ⇡ 301% 11.1 18.6 2.77
EPS ⇡ 304% ₹ 2.30 ₹ 3.86 ₹ 0.57
Always welcome for any comments with your feedback or give it a like if you find it useful.
Kopran Ltd. is a fully integrated pharmaceutical company that manufactures and supplies high-quality formulations and active pharmaceutical ingredients globally.
Name - KOPRAN
Pattern - Cup and Handle
Timeframe - Monthly
Status - Breakout
Volume - Very Good
Cmp - 335
Target - 655
SL - 326 and 290
Fundamentals:
Company is virtually debt free.
Company has a healthy Interest coverage ratio of 10.89.
The company has an efficient Cash Conversion Cycle of 43.79 days.
Company has a healthy liquidity position with current ratio of 2.22.
The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.33.
The company has shown a poor revenue growth of 14.84% for the Past 3 years.
Company has a poor ROE of 6.79% over the past 3 years.
Price ₹ 336 M.Cap ₹ 1,617 Cr PE 27.3
Item YOY Jun 2024 Mar 2024 Jun 2023
Sales ⇡ 19% 139 186 117
EBIDT ⇡ 188% 18.2 21.7 6.31
Net profit ⇡ 301% 11.1 18.6 2.77
EPS ⇡ 304% ₹ 2.30 ₹ 3.86 ₹ 0.57
Always welcome for any comments with your feedback or give it a like if you find it useful.
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.